Could a less invasive heart monitor replace the standard in sick children?
NCT ID NCT03172689
First seen Jul 15, 2026 · Last updated Jul 16, 2026 · Updated 1 time
Summary
This study compares a less invasive device that uses sound waves to measure blood flow from the heart (esophageal Doppler) with a standard, more invasive method (transpulmonary thermodilution) in children who are sedated and on breathing machines. The goal is to see if the gentler approach gives equally reliable readings of cardiac output and stroke volume. If it does, it could offer a safer way to monitor heart function in critically ill young patients.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- CardioQ (esophageal Doppler cardiac output monitor) compared to PiCCO (transpulmonary thermodilution cardiac output monitor)
- What this could lead to
- If successful, this could validate a less invasive way to measure heart function in critically ill children, potentially reducing risks associated with more invasive monitoring.
- What could go wrong
- This is a small validation study with only 11 participants, so results may not apply broadly. The device may not match the accuracy of the standard method.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARDIAC OUTPUT are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Radboud Univeristy Medical Center
Nijmegen, Gelderland, 6500 HB, Netherlands
More trials for these conditions
Other studies related to the condition(s) this trial covers.